Skip to search formSkip to main contentSkip to account menu

clopimozide

Known as: 5-chloro-1-(4-(4,4-bis(p-fluorophenyl)butyl)-4- piperidyl)-2-benzimidazolinone 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Domperidone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Metabolic Consequences of Antipsychotic Medication in Youths with Type 1 Diabetes: Analysis from the Prospective Nationwide German and Austrian Diabetes Survey DPV
1979
1979
Evidence that pimozide is not a partial agonist of dopamine receptors.
1978
1978
Differential effects of dopamine antagonists on prolactin secretion from cultured rat pituitary cells.
1978
1978
Clinical experiments with the new oral long-acting neuroleptic clopimozide (R 29 764).
A pilot study with the new oral long-acting neuroleptic agent clopimozide, a diphenylbutylpiperidine derivative, has been… 
1976
1976
[Long-acting neuroleptics. IV. Preliminary study of clopimozide (R 29764)].
Clopimozide is, in our opinion, a noteworthy neuroleptic drug. Its action is mainly ataraxic but also antidelusional, long-acting… 
1976
1976
[Treatment of chronic psychoses with oral clopimozide].
A longterm investigation containing three distinct studies has been carried out in order to clarify efficacy and inocuity of… 
1975
1975
Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Clopimozide (R 29 764), 5-chloro-1-(4-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl)-2-benzimidazolinone, is a new member of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)